UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021225
Receipt number R000024486
Scientific Title Effects of continous plasma filtration with dialysis therapy in severe septic patients with acute liver failure
Date of disclosure of the study information 2016/02/27
Last modified on 2020/03/13 14:41:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of continous plasma filtration with dialysis therapy in severe septic patients with acute liver failure

Acronym

Effects of CPDF in severe septic patients with acute liver failure

Scientific Title

Effects of continous plasma filtration with dialysis therapy in severe septic patients with acute liver failure

Scientific Title:Acronym

Effects of CPDF in severe septic patients with acute liver failure

Region

Japan


Condition

Condition

severe sepsis with acute liver failure

Classification by specialty

Gastroenterology Infectious disease Hepato-biliary-pancreatic surgery
Intensive care medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We evaluated the effects of CPDF therapy in severe septic patients with acute liver failure.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase III


Assessment

Primary outcomes

Changes in the severity score (APACHE II and SOFA) at 5 days after CPDF therapy

Key secondary outcomes

Duration of ICU stay, duration of hospitality, survival rate at 28day after CPDF therapy, and changes in hemodynamics and respiratory function and biochemical data


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

CPDF therapy (+)
It is possible to treat CPDF therapy for 7 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with both the criteria of sepsis and the criteria of acute liver failure.
Sepsis is defined as SIRS with infection.
Acute liver failure is defined as PT 40% or PT-INR >1,5 within 8 weeks.

Key exclusion criteria

1) During pregnancy or breast-feeding
2) The doctor has been deemed inappropriate
3) Not obtain consent from the patient or families

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takumi Taniguchi

Organization

Kanazawa University Hospital

Division name

Intensive Care Unit

Zip code


Address

13-1 Takara-machi, Kanazawa

TEL

076-265-2430

Email

ttaniyan@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takumi Taniguchi

Organization

Kanazawa University Hospital

Division name

Intensive Care Unit

Zip code


Address

13-1 Takara-machi, Kanazawa

TEL

076-265-2430

Homepage URL


Email

ttaniyan@med.kanazawa-u.ac.jp


Sponsor or person

Institute

Kanazawa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Intensive Care Unit, Kanazawa University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢大学附属病院(石川県)


Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 05 Month 01 Day

Date of IRB

2015 Year 04 Month 23 Day

Anticipated trial start date

2016 Year 02 Month 27 Day

Last follow-up date

2018 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 27 Day

Last modified on

2020 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024486


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name